Geode Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Buy |
1,124,160
+120,098
| +12% | +$542K | ﹤0.01% | 2721 |
|
|
2025
Q1 | $4.66M | Sell |
1,004,062
-32,603
| -3% | -$151K | ﹤0.01% | 2688 |
|
|
2024
Q4 | $7.2M | Sell |
1,036,665
-8,024
| -0.8% | -$55.7K | ﹤0.01% | 2551 |
|
|
2024
Q3 | $5.54M | Buy |
1,044,689
+197,247
| +23% | +$1.05M | ﹤0.01% | 2706 |
|
|
2024
Q2 | $3.17M | Buy |
847,442
+111,909
| +15% | +$419K | ﹤0.01% | 2958 |
|
|
2024
Q1 | $5.19M | Buy |
735,533
+47,862
| +7% | +$337K | ﹤0.01% | 2684 |
|
|
2023
Q4 | $3.89M | Buy |
687,671
+40,183
| +6% | +$227K | ﹤0.01% | 2831 |
|
|
2023
Q3 | $3.1M | Buy |
647,488
+34,257
| +6% | +$164K | ﹤0.01% | 2883 |
|
|
2023
Q2 | $4.2M | Buy |
613,231
+30,142
| +5% | +$206K | ﹤0.01% | 2782 |
|
|
2023
Q1 | $4.54M | Buy |
583,089
+19,742
| +4% | +$154K | ﹤0.01% | 2676 |
|
|
2022
Q4 | $4.29M | Buy |
563,347
+33,235
| +6% | +$253K | ﹤0.01% | 2744 |
|
|
2022
Q3 | $4.33M | Buy |
530,112
+152,109
| +40% | +$1.24M | ﹤0.01% | 2751 |
|
|
2022
Q2 | $3.66M | Buy |
378,003
+20,328
| +6% | +$197K | ﹤0.01% | 2868 |
|
|
2022
Q1 | $5.01M | Buy |
357,675
+141,674
| +66% | +$1.99M | ﹤0.01% | 2799 |
|
|
2021
Q4 | $4.41M | Buy |
216,001
+20,218
| +10% | +$413K | ﹤0.01% | 2962 |
|
|
2021
Q3 | $4.36M | Buy |
+195,783
| New | +$4.36M | ﹤0.01% | 2989 |
|